Suppr超能文献

丝氨酸蛋白酶抑制剂E1/纤溶酶原激活物抑制剂-1基因调控分子交响乐中配体激活转录因子的协同作用

Orchestra of ligand-activated transcription factors in the molecular symphony of SERPINE 1 / PAI-1 gene regulation.

作者信息

Vrzalova Aneta, Vrzal Radim

机构信息

Department of Cell Biology and Genetics, Faculty of Science, Palacky University, Slechtitelu 27, 783 71 Olomouc, Czech Republic.

Department of Cell Biology and Genetics, Faculty of Science, Palacky University, Slechtitelu 27, 783 71 Olomouc, Czech Republic.

出版信息

Biochimie. 2025 Jan;228:138-157. doi: 10.1016/j.biochi.2024.09.010. Epub 2024 Sep 23.

Abstract

Plasminogen activator inhibitor 1 (PAI-1) is a crucial serine protease inhibitor that prevents plasminogen activation by inhibiting tissue- and urokinase-type plasminogen activators (tPA, uPA). PAI-1 is well-known for its role in modulating hemocoagulation or extracellular matrix formation by inhibiting plasmin or matrix metalloproteinases, respectively. PAI-1 is induced by pro-inflammatory cytokines across various tissues, yet its regulation by ligand-activated transcription factors is partly disregarded. Therefore, we have attempted to summarize the current knowledge on the transcriptional regulation of PAI-1 expression by the most relevant xenobiotic and endocrine receptors implicated in modulating PAI-1 levels. This review aims to contribute to the understanding of the specific, often tissue-dependent regulation of PAI-1 and provide insights into the modulation of PAI-1 levels beyond its direct inhibition.

摘要

纤溶酶原激活物抑制剂1(PAI-1)是一种关键的丝氨酸蛋白酶抑制剂,它通过抑制组织型和尿激酶型纤溶酶原激活物(tPA、uPA)来阻止纤溶酶原的激活。PAI-1分别通过抑制纤溶酶或基质金属蛋白酶在调节血液凝固或细胞外基质形成中所起的作用而闻名。PAI-1由多种组织中的促炎细胞因子诱导产生,但其受配体激活转录因子的调控在一定程度上被忽视。因此,我们试图总结目前关于参与调节PAI-1水平的最相关的外源性和内分泌受体对PAI-1表达转录调控的认识。本综述旨在促进对PAI-1特异性的、通常依赖于组织的调控的理解,并深入了解除直接抑制之外对PAI-1水平的调节。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验